Provided by Tiger Trade Technology Pte. Ltd.

ETF & Stock Investment

2,072.72
-4.6323-0.22%
Number of Gainers:388
Number of Losers:619
Number of Flat:17
PE:- -
High:2,088.77
Open:2,077.40
Low:2,070.10
Close:2,077.35
Volume:4.94B
Turnover:647.60B
Market Cap:96.59T
Float Cap:90.42T

Loading ...

Seamec Limited Concludes ONGC Charter for Offshore Vessel SEAMEC II

TIPRANKS
·
36 mins ago

Jobs, Broadcom, Dell, Hewlett, Planet Labs, and More to Watch This Week

Dow Jones
·
59 mins ago

Analysts Conflicted on These Consumer Cyclical Names: Carnival (CCL) and Ulta Beauty (ULTA)

TIPRANKS
·
1 hour ago

PPG Industries (PPG) Gets a Hold from Argus Research

TIPRANKS
·
1 hour ago

Brown & Brown (BRO) Receives a Sell from Morgan Stanley

TIPRANKS
·
1 hour ago

Analysts Have Conflicting Sentiments on These Consumer Cyclical Companies: Norwegian Cruise Line (NCLH), Burlington Stores (BURL) and Ulta Beauty (ULTA)

TIPRANKS
·
1 hour ago

Analysts’ Opinions Are Mixed on These Technology Stocks: Nvidia (NVDA), MongoDB (MDB) and Yangtze Optical Fibre and Cable Joint Stock Co (OtherYZOFF)

TIPRANKS
·
1 hour ago

Analysts Offer Insights on Consumer Cyclical Companies: Gap Inc (GAP) and Shenzhou International Group Holdings (OtherSZHIF)

TIPRANKS
·
1 hour ago

Futures Set to Trade Ahead of Jobs Data, Tech Earnings

Dow Jones
·
2 hours ago

Can Nvidia and SpaceX Make Orbital AI Computing a Reality?

TIPRANKS
·
2 hours ago

Trump: Retweets praise of his job record, Boeing deal

Trump's Truth Social latest posts
·
2 hours ago

Trump: Bangladesh commits billions to buy Boeing aircraft

Trump's Truth Social latest posts
·
2 hours ago

What Is Drawing Fresh Attention To China Coal Energy (SEHK:1898)?

Simply Wall St.
·
2 hours ago

Trump: Bangladesh commits billions to buy more Boeing aircraft

Trump's Truth Social latest posts
·
2 hours ago

Trump: $Billion Boeing Deal with Bangladesh

Trump's Truth Social latest posts
·
2 hours ago

港股8月31日重要日程一览:新股、业绩、分红等关键信息汇总

Stock News
·
2 hours ago

Aon Nears Roughly $17 Billion Deal for Insurance Brokerage Usi from KKR - WSJ

THOMSON REUTERS
·
Yesterday

Arrowhead Pharmaceuticals - Plozasiran Demonstrated Favorable Safety and Tolerability Profile in Phase 3 Studies

THOMSON REUTERS
·
Yesterday

Arrowhead Pharmaceuticals - to File Supplemental Nda with U.S. FDA by Year-End 2026 Using Priority Review Voucher

THOMSON REUTERS
·
Yesterday

Arrowhead Pharmaceuticals Presents Phase 3 Shasta-3 and Shasta-4 Data Demonstrating Plozasiran Reduced Acute Pancreatitis Events in Patients with Severe Hypertriglyceridemia

THOMSON REUTERS
·
Yesterday